GPER1 and breast carcinoma: Findings that GPER activation by E2 or G1 may regulate the expression of certain miRNAs and trigger tumorigenic effects in breast cancer, provide new knowledge of the molecular mechanism involved in this neoplasia that would be useful, not only toward innovative therapeutic approaches, but also to understand the failure of treatment in oncological patients.